Fig. 4From: Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastomaSurvival analysis of patients with glioma. Kaplan–Meier analyses were performed based on the median expression levels of the eight DEGs in the TCGA-GBMLGG (a) and CGGA (b) cohorts. The tick marks on the Kaplan–Meier survival curves represent the censored subjects. TCGA: The Cancer Genome Atlas; CGGA: the Chinese Glioma Genome AtlasBack to article page